Research - San Diego, California, United States
Providing preclinical and early development solutions for emerging biotech.My focus is tailoring cost-effective early development solutions to emerging biotech (e.g. virtual companies, university spinoffs) worldwide. Over the last 20 years, I have managed more than 50 drug development projects and programs - small molecule, peptides and various types of biologicals (e.g. antibodies, recombinant proteins, ADCs) - from target discovery to early development, for a variety of indications (oncology, inflammation, infective, hormonal, rare diseases etc). I am a Doctor of Veterinary Medicine, PhD, Adj Professor of Toxicology, and I have Toxicology Board Certification both from the US (DABT; 2006-) and Europe (ERT; 2004-). I shared my time btw California, China and Australia since 2012. I am deeply familiar with utilization of the top FDA-inspected preclinical CROs and manufacturing CMOs in China and clinical CROs in Australia. This has allowed the completion of IND-enabling programs in some cases with less than $400,000, followed by a completion of clinical trials in cancer patients for less than $2,000,000. In addition to providing input to specific technical areas such as toxicology, I have managed biotech companies as an executive consultant, being responsible for all daily operations of a company.
Outlook
Typekit
Mobile Friendly